Learn more about our Diagnostics work.
AdvaMed®, the world’s largest trade organization representing medical technology companies and innovators, announced today that the AdvaMedDx® Board of Directors unanimously selected Zach Rothstein as AdvaMedDx®’s new Executive Director. In…
The VALID Act is carefully tailored to ensure continued access to tests offered by academic medical centers and other laboratories.
October is Breast Cancer Awareness Month and a good time to remember the importance of diagnostic screenings in saving lives.
This report outlines a key data-driven summary of the U.S. COVID testing supply.
CEO and surgeon Dr. Lishan Aklog speaks about the tremendous value of medical technology, the sharp disparities patients face, and the importance of policymaking to ease those disparities.
AdvaMed® submitted a letter to Medicare Administrative Contractors, Novitas and First Coast Service Options, regarding proposed LCDs on Genetic Testing in Oncology.
This report examines cumulative data from the first two years of the COVID Test Registry to demonstrate the mobilization of the diagnostics industry over the course of the pandemic.
Read a section-by-section breakdown of the Verifying Accurate Leading-edge IVCT Development (VALID) Act of 2021.
The Advanced Medical Technology Association® (AdvaMed®), working in the United Kingdom with the Medical Technology Group (MTG) and the Association of British HealthTech Industries (ABHI), commends the recent announcement by the UK Government of aggressive polices to address…